{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:58:47Z","timestamp":1791104327107,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00415-008-5010-5","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T13:28:10Z","timestamp":1221139690000},"page":"48-56","source":"Crossref","is-referenced-by-count":64,"title":["Parkinson\u2019s disease-related disorders in the impulsive-compulsive spectrum"],"prefix":"10.1007","volume":"255","author":[{"given":"Eric Ch.","family":"Wolters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ysbrand D.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile A.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,12]]},"reference":[{"key":"5010_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG, et al. (1999) Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67:492\u2013496","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5010_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.70.3.394","volume":"70","author":"Alegret","year":"2001","unstructured":"Alegret M, Junque C, Vendrell P, Marti MJ, Tolosa E (2001) Obsessive-compulsive symptoms in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 70:394\u2013396","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5010_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","volume":"85","author":"Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions. Prog Brain Res 85:119\u2013146","journal-title":"Prog Brain Res"},{"key":"5010_CR4","unstructured":"American Psychiatric Association Diagnostic and statistic manual of mental disorders (1997) 4th ed Washington: American Psychiatric Press"},{"key":"5010_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2004.06.005","volume":"76","author":"Bearn","year":"2004","unstructured":"Bearn J, Evans A, Kelleher M, Turner K, Lees A (2004) Recognition of a dopamine replacement therapy dependence syndrome in Parkinson\u2019s disease: a pilot study. Drug Alcohol Depend 76:305\u2013310","journal-title":"Drug Alcohol Depend"},{"key":"5010_CR6","first-page":"14","volume":"6","author":"Black","year":"2007","unstructured":"Black DW (2007)A review of compulsive buying disorder. World Psychiatry 6:14\u201318","journal-title":"World Psychiatry"},{"key":"5010_CR7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, et al. (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60:1745\u20131748","journal-title":"Arch Neurol"},{"key":"5010_CR8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ana.20878","volume":"59","author":"Bonci","year":"2006","unstructured":"Bonci A, Singh V (2006) Dopamine dysregulation syndrome in Parkinson\u2019s disease patients: from reward to penalty. Ann Neurol 59:733\u2013734","journal-title":"Ann Neurol"},{"key":"5010_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","volume":"26","author":"Booij","year":"1999","unstructured":"Booij J, Tissingh G, Winogrodzka A, van Royen EA (1999) Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 26:171\u2013182","journal-title":"Eur J Nucl Med"},{"key":"5010_CR10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","volume":"111","author":"Bosboom","year":"2004","unstructured":"Bosboom JLW, Stoffers D, Wolters ECh (2004) Cognitive function in Parkinson\u2019s disease. J Neural Transm 111:1303\u20131315","journal-title":"J Neural Transm"},{"key":"5010_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rueb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"5010_CR12","unstructured":"Brooks JJ (2006) Imaging the dopamine system in Parkinson\u2019s disease. In: Wolters ECh, Berendse HW, Stam CJ (eds) Mental dysfunction in Parkinson\u2019s disease III Amsterdam: VU Medical Press, pp 247\u2013264"},{"key":"5010_CR13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","volume":"62","author":"Dodd","year":"2005","unstructured":"Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377\u20131381","journal-title":"Arch Neurol"},{"key":"5010_CR14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","volume":"60","author":"Doder","year":"2003","unstructured":"Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ (2003) Tremor in Parkinson\u2019s disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 60:601\u2013605","journal-title":"Neurology"},{"key":"5010_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","volume":"17","author":"Evans","year":"2004","unstructured":"Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson\u2019s disease. Curr Opin Neurol 17:393\u2013398","journal-title":"Curr Opin Neurol"},{"key":"5010_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, et al. (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405","journal-title":"Mov Disord"},{"key":"5010_CR17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","volume":"59","author":"Evans","year":"2006","unstructured":"Evans AH, Pavese N, Lawrence AD, et al. (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59:852\u2013858","journal-title":"Ann Neurol"},{"key":"5010_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.09.025","volume":"526","author":"Franken","year":"2005","unstructured":"Franken IH, Booij J, Brink BW van den (2005) The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol 526:199\u2013206","journal-title":"Eur J Pharmacol"},{"key":"5010_CR19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-3223(94)90636-X","volume":"36","author":"Friedman","year":"1994","unstructured":"Friedman JH (1994) Punding on levodopa. Biol Psychiatry 36:350\u2013351","journal-title":"Biol Psychiatry"},{"key":"5010_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5010_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0079-6123(08)62677-1","volume":"85","author":"Groenewegen","year":"1990","unstructured":"Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res 85:95\u2013116","journal-title":"Prog Brain Res"},{"key":"5010_CR22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0387-7604(03)90001-5","volume":"25","author":"Groenewegen","year":"2003","unstructured":"Groenewegen HJ, van den Heuvel OA, Cath DC, Voorn P, Veltman DJ (2003) Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette\u2019s syndrome? A neuronal circuit approach. Brain Dev 25 (Suppl 1):S3\u2013S14","journal-title":"Brain Dev"},{"key":"5010_CR23","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"Haber","year":"2000","unstructured":"Haber SN, Fudge JL, McFarland NR (2000) Striato-nigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20:2369\u20132382","journal-title":"J Neurosci"},{"key":"5010_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2004.07.006","volume":"11","author":"Harbishettar","year":"2005","unstructured":"Harbishettar V, Kumar Pal P, Reddy YCJ, Thennarasu K (2005) Is there a relationship between Parkinson\u2019s disease and obsessive-compulsive disorder? Parkinsonism Relat Disord 11:85\u201388","journal-title":"Parkinsonism Relat Disord"},{"key":"5010_CR25","first-page":"3","volume":"56","author":"Hollander","year":"1995","unstructured":"Hollander E, Wong CM (1995) Obsessive-compulsive spectrum disorders. J Clin Psychiatry 56(Suppl 4):3\u20136","journal-title":"J Clin Psychiatry"},{"key":"5010_CR26","first-page":"3","volume":"57","author":"Hollander","year":"1996","unstructured":"Hollander E, Kwon JH, Stein DJ, Broatch J, Rowland CT, Himelein CA (1996) Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry 57(Suppl 8):3\u20136","journal-title":"J Clin Psychiatry"},{"key":"5010_CR27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, Gaspari D de, Pezzo IG, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:411\u2013415","journal-title":"Mov Disord"},{"key":"5010_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbr.2004.07.006","volume":"157","author":"Joel","year":"2005","unstructured":"Joel D, Zohar O, Afek M, Hermesh H, Lerner L, Kuperman R, Gross-Isseroff R, Weizman A, Inzelberg R (2005) Impaired procedural learning in obsessive-compulsive disorder and Parkinson\u2019s disease, but not in major depressive disorder. Behav Brain Research 157:253\u2013263","journal-title":"Behav Brain Research"},{"key":"5010_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.21780","volume":"23","author":"Kashihara","year":"2008","unstructured":"Kashihara K, Imamura T (2008) Amantadine may reverse punding in Parkinson\u2019s disease-observation in a patient. Mov Disord 23:129\u2013130","journal-title":"Mov Disord"},{"key":"5010_CR30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","volume":"11","author":"Klos","year":"2005","unstructured":"Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE (2005) Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy Parkinsonism. Relat Disord 11:381\u2013386","journal-title":"Relat Disord"},{"key":"5010_CR31","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1176\/ajp.2006.163.10.1806","volume":"163","author":"Koran","year":"2006","unstructured":"Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT (2006) Estimated prevalence of compulsive buying in the United States. Am J Psychiatry 163:1806\u20131812","journal-title":"Am J Psychiatry"},{"key":"5010_CR32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","volume":"2","author":"Lawrence","year":"2003","unstructured":"Lawrence AD, Evans AH, Lees AJ (2003) Compulsive use of dopamine replacement therapy in Parkinson\u2019s disease: reward systems gone awry? Lancet Neurol 2:595\u2013604","journal-title":"Lancet Neurol"},{"key":"5010_CR33","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/mds.21702","volume":"22","author":"Lawrence","year":"2007","unstructured":"Lawrence AJ, Blackwell AD, Barker RA, et al. (2007) Predictors of punding in Parkinson\u2019s disease: Results from a questionnaire survey. Mov Disord 22:2339\u20132345","journal-title":"Mov Disord"},{"key":"5010_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE, et al. (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380","journal-title":"Mov Disord"},{"key":"5010_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.neuropsych.15.3.371","volume":"15","author":"Maia","year":"2003","unstructured":"Maia AF, Pinto AS, Barbaros ER, Menezes PR, Miguel EC (2003) Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 15:371\u2013374","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"5010_CR36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.parkreldis.2007.04.004","volume":"13","author":"McKeon","year":"2007","unstructured":"McKeon A, Josephs KA, Klos KJ, Hecksel K, Bower JH, Bostwick M, Ahlskog JE (2007) Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy. Pakinsonism Relat Disord 13:516\u2013519","journal-title":"Pakinsonism Relat Disord"},{"key":"5010_CR37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.21296","volume":"22","author":"Miyasaki","year":"2007","unstructured":"Miyasaki JM, Al Hassan K, Lang AE, Voon V (2007) Punding prevalence in Parkinson\u2019s disease. Mov Disord 22:1179\u20131181","journal-title":"Mov Disord"},{"key":"5010_CR38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","volume":"15","author":"Molina","year":"2000","unstructured":"Molina JA, Sainz-Artiga MJ, Fraile A, et al. (2000) Pathologic gambling in Parkinson\u2019s disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 15:869\u2013872","journal-title":"Mov Disord"},{"key":"5010_CR39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/appi.neuropsych.13.2.222","volume":"13","author":"Murai","year":"2001","unstructured":"Murai T, Muller U, Werheid K, et al. (2001) In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 13:222\u2013228","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"5010_CR40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.STR.0000260088.07611.6e","volume":"38","author":"Nguygen","year":"2007","unstructured":"Nguygen FN, Pauly RR, Okun MS, Fernandez HH (2007) Punding as a complication of brain stem stroke?: report of a case Stroke 38:1390\u20131392","journal-title":"Stroke"},{"key":"5010_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","volume":"14","author":"Ondo","year":"2008","unstructured":"Ondo WG, Lai D (2008) Predictors of impulsivity and reward seeking behaviour with dopamine agonists parkinsonism. Relat Disord 14:28\u201332","journal-title":"Relat Disord"},{"key":"5010_CR42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jnnp.2007.129015","volume":"7","author":"O\u2019Sullivan","year":"2007","unstructured":"O\u2019Sullivan SS, Evans AH, Lees AJ (2007) Punding in Parkinson\u2019s disease. Practical Neurology 7:397\u2013399","journal-title":"Practical Neurology"},{"key":"5010_CR43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0680","volume":"3","author":"Potenza","year":"2007","unstructured":"Potenza MN, Voon V, Weintraub D (2007) Drug insight: impulse control disorders and dopamine therapies in Parkinson\u2019s disease. Nature Clin Pract Neurol 3:664\u2013672","journal-title":"Nature Clin Pract Neurol"},{"key":"5010_CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/157340505774574808","volume":"1","author":"Remijnse","year":"2005","unstructured":"Remijnse PL, van den Heuvel OA, Veltman DJ (2005) Neuroimaging in obsessive-compulsive disorder. Current Medical Imaging Reviews 1:331\u2013351","journal-title":"Current Medical Imaging Reviews"},{"key":"5010_CR45","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314\u20131322","journal-title":"Brain"},{"key":"5010_CR46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mds.10265","volume":"17","author":"Romito","year":"2002","unstructured":"Romito LM, Raja M, Daniele A, et al. (2002) Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson\u2019s disease. Mov Disord 17:1371\u20131374","journal-title":"Mov Disord"},{"key":"5010_CR47","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1523\/JNEUROSCI.1072-04.2004","volume":"24","author":"Saka","year":"2004","unstructured":"Saka E, Goodrich C, Harlan P, Madras BK, Graybiel AM (2004) Repetitive behaviors in monkeys are linked to specific striatal activation patterns. J Neurosci 24:7557\u20137565","journal-title":"J Neurosci"},{"key":"5010_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JCP.0b013e31802e98c3","volume":"27","author":"Sevincok","year":"2007","unstructured":"Sevincok L, Akoglu A, Akyol A (2007) Quetiapine in a case with Parkinson\u2019s disease and pathological gambling. J Clin Psychopharmacol 27:107\u2013108","journal-title":"J Clin Psychopharmacol"},{"key":"5010_CR49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","volume":"15","author":"Shiba","year":"2000","unstructured":"Shiba M, Bower JH, Maraganore DM, et al. (2000) Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: a case-control study. Mov Disord 15:669\u2013677","journal-title":"Mov Disord"},{"key":"5010_CR50","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/mds.21118","volume":"21","author":"Silveira-Moriyama","year":"2006","unstructured":"Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ (2006) Punding and dyskinesias. Mov Disord 21:2214\u20132217","journal-title":"Mov Disord"},{"key":"5010_CR51","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jns.2007.08.015","volume":"266","author":"Truong","year":"2008","unstructured":"Truong DD, Bhidayasiri R, Wolters E (2008) Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci 266:216\u2013228","journal-title":"J Neurol Sci"},{"key":"5010_CR52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2004.10.007","volume":"11","author":"Uitti","year":"2005","unstructured":"Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ (2005) Defining the Parkinson disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord 11:139\u2013145","journal-title":"Parkinsonism Relat Disord"},{"key":"5010_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.1113","volume":"43","author":"van de Witte","year":"2002","unstructured":"van de Witte SV, Groenewegen HJ, Voorn P (2002) MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Synapse 43:1\u201311","journal-title":"Synapse"},{"key":"5010_CR54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.62.8.922","volume":"62","author":"van den Heuvel","year":"2005","unstructured":"van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. (2005) Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch General Psychiat 62:922\u2013933","journal-title":"Arch General Psychiat"},{"key":"5010_CR55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2005.08.050","volume":"136","author":"van Dongen","year":"2005","unstructured":"van Dongen YC, Deniau JM, Pennartz CM, et al. (2005) Anatomical evidence for direct connections between the shell and core subregions of the rat nucleus accumbens. Neuroscience 136:1049\u20131071","journal-title":"Neuroscience"},{"key":"5010_CR56","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, et al. (2006) Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66:1750\u20131752","journal-title":"Neurology"},{"key":"5010_CR57","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson\u2019s disease. Neurology 67:1254\u20131257","journal-title":"Neurology"},{"key":"5010_CR58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/WCO.0b013e32826fbc8f","volume":"20","author":"Voon","year":"2007","unstructured":"Voon V, Potenza MN, Thompsen T (2007) Medication-related impulse control and repetitive behaviors in Parkinson\u2019s disease. Curr Opin Neurol 20:484\u2013492","journal-title":"Curr Opin Neurol"},{"key":"5010_CR59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","volume":"64","author":"Voon","year":"2007","unstructured":"Voon V, Thompsen T, Miyasaki JM, et al. (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson\u2019s disease. Arch Neurol 64:212\u2013216","journal-title":"Arch Neurol"},{"key":"5010_CR60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"Weintraub","year":"2006","unstructured":"Weintraub D, Siderowf AD, Potenza MN, et al. (2006) Association of dopamine agonist use with impulse control disorders in Parkinson\u2019s disease. Arch Neurol 63:969\u2013973","journal-title":"Arch Neurol"},{"key":"5010_CR61","doi-asserted-by":"crossref","first-page":"II103","DOI":"10.1007\/PL00022910","volume":"247","author":"Wolters","year":"2000","unstructured":"Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC (2000) Preclinical (premotor) Parkinson\u2019s disease. J Neurol 247:II103\u2013II109","journal-title":"J Neurol"},{"key":"5010_CR62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","volume":"70","author":"Wolters","year":"2006","unstructured":"Wolters E, Braak H (2006) Parkinson\u2019s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309\u2013319","journal-title":"J Neural Transm Suppl"},{"key":"5010_CR63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2007.08.016","volume":"266","author":"Wolters","year":"2008","unstructured":"Wolters ECh (2008) Variability in the clinical expression of Parkinson\u2019s disease. J Neurol Sci 266:197\u2013203","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-5010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-5010-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-5010-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:44:55Z","timestamp":1709232295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-5010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":63,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["5010"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-5010-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}